Benjamin L Palleiko $KALV SEC Form 4 Insider Trading

Benjamin L Palleiko has filed a total of 32 insider trades in $KALV since 2021. Their most recent trade was a sale of 9,550 shares, made on Apr 17, 2026. Their largest trade was a sale of 40,855 shares, made on Feb 14, 2024. We estimate that they now own 462,577 shares of $KALV, worth an estimated $12.4 million.

Insider Trading at $KALV

There have been a total of 170 insider trades reported at $KALV since 2021, with 1.6 million shares purchased and 1.2 million shares sold. The most active insider traders in $KALV stock have been Benjamin L Palleiko, Christopher Yea, and Paul K. Audhya. The most recent trade was a sale of 2,686 shares reported by Paul K. Audhya (CHIEF MEDICAL OFFICER), made on Apr 17, 2026.

$KALV Executives and Stock Owners with Insider Trades

• Benjamin L Palleiko, CHIEF EXECUTIVE OFFICER

• Christopher Yea, CHIEF DEVELOPMENT OFFICER

• Paul K. Audhya, CHIEF MEDICAL OFFICER

• Thomas Andrew Crockett, CEO

• Edward P. Feener, Chief Scientific Officer

• Christopher Yea, Chief Development Officer

• Paul K. Audhya, Chief Medical Officer

• Edward P. Feener, CHIEF SCIENTIFIC OFFICER

• Nicole Sweeny, Chief Commercial Officer

• Benjamin L Palleiko, President, CFO, CBO & Sec'y

• Brian Piekos, Chief Financial Officer

• Benjamin L Palleiko, CFO, CBO

• Benjamin L Palleiko, CFO, CBO & Secretary

• Michael David Smith, Senior VP, Development

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.